Chemicals & Advanced Materials Global On demand · 24-48h

Global Lutetium-177 (Lu-177) Market Strategic Research Report

Global Lutetium-177 (Lu-177) Market Strategic Research Repor…
$3,500 USD
Market Research Reports
Strategic Research Report
Global Lutetium-177 (Lu-177) Market
$2.5B2025
16.5%CAGR
2032Forecast
Market Research Reports · Global
Market Research Reports Intelligence Series

By Type: Non-carrier-added, Carrier-added

By Application: Nuclear Therapy, Others

Regional Forecast: Asia Pacific, Latin America, MEA, Europe, North America

Key Players: Advanced Accelerator Applications (Novartis), Eckert & Ziegler Strahlen, SHINE Technologies, ANSTO, NTP Radioisotopes

Region: Global
Formats: PDF, Excel, Word & PowerPoint
Base year: 2025 · forecast to 2032
Length: 83 pages
Market size 2025
$2.5B
Billion USD
Forecast CAGR
16.5%
2025-2032
Forecast 2032
$7.3B
Projected
Gebieden
5
Asia Pacific · Latin America · MEA · Europe · North America

Overzicht

Scope of the Report

The global Lutetium-177 (Lu-177) market size is predicted to grow from US$ 2,498 million in 2025 to US$ 7,189 million in 2032; it is expected to grow at a CAGR of 16.5% from 2026 to 2032.

Lutetium-177 (Lu-177) is a radioactive isotope of lutetium, a rare-earth metal with the atomic number 71. It has a half-life of approximately 6.6 days and emits beta and gamma radiation. Lutetium-177 is used in nuclear medicine for the treatment of various cancers, such as neuroendocrine tumors, breast cancer, and prostate cancer. It is often combined with other radionuclides or chelating agents to form radiolabeled tracers for imaging or therapeutic purposes. Targeted cancer therapy: Lu-177 can be used to treat somatostatin receptor-positive gastroenteropancreatic neuroendocrine tumors. It achieves targeted therapy of tumors by binding to somatostatin receptors on the tumor surface. Prostate cancer treatment: Lu-177 can combine with prostate-specific membrane antigen (PSMA) to form Lu-177 PSMA, which is used to treat advanced prostate cancer. This treatment shrinks or kills tumor cells and relieves pain and other clinical manifestations of metastatic prostate cancer. Neuroendocrine tumor treatment: Neuroendocrine tumors express somatostatin receptors, so Lu-177 can bind to these receptors to achieve targeted therapy of tumors. Compared with traditional cancer treatments, Lu-177 treatment reduces hospital stay, does not affect healthy tissue, and is safe and well-tolerated.

Global key players of Lutetium-177 (Lu-177) include Advanced Accelerator Applications (Novartis), Eckert & Ziegler Strahlen, SHINE Technologies, etc. The top three players hold a share about 98%. North America is the largest market, and has a share about 44%, followed by Europe and Asia-Pacific with share 33% and 18%, separately. In terms of product type, Non-carrier-added is the largest segment, accounting for a share of 99%. In terms of application, Nuclear Therapy is the largest field with a share about 98 percent.

This report presents a comprehensive overview of the global Lutetium-177 (Lu-177) market, covering market size and forecast, segmentation by product type and application, competitive landscape, leading players and regional and country-level outlook.

Segment by Type

  • Non-carrier-added
  • Carrier-added

Segment by Application

  • Nuclear Therapy
  • Others

Who Can Use This Report?

This report is written for decision-makers who need a clear, data-backed view of the global Lutetium-177 (Lu-177) market:

  • Manufacturers, suppliers and solution providers benchmarking their position and planning product, capacity and go-to-market strategy
  • Distributors, channel partners and end users in Nuclear Therapy, Others evaluating demand and sourcing options
  • Investors, financial analysts and consultants assessing growth opportunities, competitive dynamics and M&A potential
  • Government agencies, industry associations and research institutions tracking industry developments and policy impact

Market snapshot

Global Lutetium-177 (Lu-177) Market Strategic Research Report snapshot, 2025–2032

Source: Market Research Reports
Market size CAGR 16.5%
Regional growth momentum
Market share by segment
Key metrics
Base value
$2.5B
2025
Forecast
$7.3B
2032
CAGR
16.5%
2025–2032
Gebieden
5
global
Key companies
Advanced Accelerator Applications (Novartis)Eckert & Ziegler StrahlenSHINE TechnologiesANSTONTP Radioisotopes
© MarketResearchReports.comDisclaimer: The actual data may vary in the final report which undergoes verification check post order confirmation.

Segments covered in this report

By Type
Non-carrier-addedCarrier-added
By Application
Nuclear TherapyOthers

Table of contents

Click a chapter to expand
01Executive Summary
02Industry Overview & Forecast
  • 2.1.1 Market Definition and Scope
  • 2.1.2 Market Size and Growth Forecast
  • 2.1.3 Volume Analysis
  • 2.1.4 Segment Outlook by Type
  • 2.1.5 Segment Outlook by Application
  • 2.1.6 Regional Outlook
  • 2.1.7 Structural Developments Shaping the Forecast
  • 2.1.8 Forecast Risks and Sensitivities
03Market Segmentation by Type
  • 3.1 Market Segmentation by Type
  • 3.1.1 Market by Type Overview
  • 3.1.2 Non-carrier-added
  • 3.1.3 Carrier-added
  • 3.1.4 Volume Analysis
04Market Segmentation by Application
  • 4.1 Market Segmentation by Application
  • 4.1.1 Market by Application Overview
  • 4.1.2 Nuclear Therapy
  • 4.1.3 Others
  • 4.1.4 Volume Analysis
05Regional Market Forecast
  • Asia Pacific
  • North America
  • Europe
  • Middle East & Africa
  • Latin America
06Country-Level Market Forecast
  • 6.1 Asia Pacific
  • 6.1.1 China
  • 6.1.2 Japan
  • 6.1.3 Korea
  • 6.1.4 Southeast Asia
  • 6.1.5 India
  • 6.1.6 Australia
  • 6.1.7 Rest of Asia Pacific
  • 6.2 North America
  • 6.2.1 United States
  • 6.2.2 Canada
  • 6.2.3 Mexico
  • 6.2.4 Rest of North America
  • 6.3 Europe
  • 6.3.1 Germany
  • 6.3.2 France
  • 6.3.3 UK
  • 6.3.4 Italy
  • 6.3.5 Russia
  • 6.3.6 Rest of Europe
  • 6.4 Middle East & Africa
  • 6.4.1 Egypt
  • 6.4.2 South Africa
  • 6.4.3 Israel
  • 6.4.4 Turkey
  • 6.4.5 GCC Countries
  • 6.4.6 Rest of Middle East & Africa
  • 6.5 Latin America
  • 6.5.1 Brazil
  • 6.5.2 Rest of Latin America
07Growth Drivers & Inhibitors
  • 7.1 Growth Drivers & Inhibitors
  • 7.1.1 Section Overview
  • 7.1.2 Growth Drivers
  • 7.1.3 Growth Inhibitors
  • 7.1.4 Driver and Inhibitor Impact Assessment
  • 7.1.5 Analyst Perspective
08Key Company Profiles
  • 8.1 Advanced Accelerator Applications (Novartis)
  • 8.1.1 Company Overview
  • 8.1.2 Key Products & Segments
  • 8.1.3 Financial Performance (2023–2025)
  • 8.1.4 Business Strategy
  • 8.1.5 SWOT Analysis
  • 8.1.6 Strategic Implications (2026–2032)
  • 8.2 Eckert & Ziegler Strahlen
  • 8.2.1 Company Overview
  • 8.2.2 Key Products & Segments
  • 8.2.3 Financial Performance (2023–2025)
  • 8.2.4 Business Strategy
  • 8.2.5 SWOT Analysis
  • 8.2.6 Strategic Implications (2026–2032)
  • 8.3 SHINE Technologies
  • 8.3.1 Company Overview
  • 8.3.2 Key Products & Segments
  • 8.3.3 Financial Performance (2023–2025)
  • 8.3.4 Business Strategy
  • 8.3.5 SWOT Analysis
  • 8.3.6 Strategic Implications (2026–2032)
  • 8.4 ANSTO
  • 8.4.1 Company Overview
  • 8.4.2 Key Products & Segments
  • 8.4.3 Financial Performance (2023–2025)
  • 8.4.4 Business Strategy
  • 8.4.5 SWOT Analysis
  • 8.4.6 Strategic Implications (2026–2032)
  • 8.5 NTP Radioisotopes
  • 8.5.1 Company Overview
  • 8.5.2 Key Products & Segments
  • 8.5.3 Financial Performance (2023–2025)
  • 8.5.4 Business Strategy
  • 8.5.5 SWOT Analysis
  • 8.5.6 Strategic Implications (2026–2032)
09Competitive Landscape
  • 9.1 Competitive Landscape Overview
  • 9.2 Competitive Intensity Assessment
  • 9.3 Key Player Strategies & Positioning
  • 9.4 Competitive Dynamics & Strategic Outlook
  • 9.4.1 Emerging Competitive Threats
  • 9.4.2 Consolidation vs. Fragmentation Outlook
  • 9.4.3 Competitive Response Matrix
  • 9.4.4 Strategic Recommendations, 2026–2032
10Porter's Five Forces Analysis
  • 10.1 Threat of New Entrants
  • 10.2 Bargaining Power of Buyers
  • 10.3 Bargaining Power of Suppliers
  • 10.4 Threat of Substitutes
  • 10.5 Competitive Rivalry
11PESTLE Analysis
  • 11.1 Political
  • 11.2 Economic
  • 11.3 Social and Demographic
  • 11.4 Technological
  • 11.5 Legal and Regulatory
  • 11.6 Environmental
  • 11.7 Strategic Implications of the PESTLE Assessment
12SWOT Analysis
13Future Trends & Outlook
  • 13.1 Future Trends & Outlook
  • 13.1.1 Trend Summary and Commercial Maturity Assessment
  • 13.1.2 Technology and Innovation Trends
  • 13.1.3 Long-Term Market Outlook
  • 13.1.4 Investment & M&A Activity Outlook
  • 13.1.5 Overall Outlook Assessment

Frequently asked questions

What is the size of the global Lutetium-177 (Lu-177) market?
The global Lutetium-177 (Lu-177) market is estimated at US$ 2.5 billion in 2025 (base year) and is projected to reach US$ 7.19 billion by 2032.
What is the forecast CAGR for the Lutetium-177 (Lu-177) market?
The market is expected to grow at a CAGR of 16.5% from 2026 to 2032, expanding from US$ 2.5 billion in 2025 to US$ 7.19 billion in 2032, roughly 2.9 times its base-year value.
What is Lutetium-177 (Lu-177)?
Lutetium-177 (Lu-177) is a radioactive isotope of lutetium, a rare-earth metal with the atomic number 71. It has a half-life of approximately 6.6 days and emits beta and gamma radiation. Lutetium-177 is used in nuclear medicine for the treatment of various cancers, such as neuroendocrine tumors, breast cancer, and prostate cancer.
How is the Lutetium-177 (Lu-177) market segmented by type?
By type, the market is segmented into Non-carrier-added and Carrier-added.
What are the key applications of Lutetium-177 (Lu-177)?
Key applications covered include Nuclear Therapy and Others.
Which companies are profiled in the Lutetium-177 (Lu-177) market report?
Key players profiled include Advanced Accelerator Applications (Novartis), Eckert & Ziegler Strahlen, SHINE Technologies, ANSTO and NTP Radioisotopes.
What geographies does the Lutetium-177 (Lu-177) market analysis include?
The market is analysed across Asia Pacific, North America, Europe, Middle East & Africa and Latin America, with 20 country-level markets including China, Japan, United States, Canada, Germany, France, Egypt and South Africa.
Who should buy the Lutetium-177 (Lu-177) market report?
The report is intended for manufacturers and solution providers, distributors and end users in Nuclear Therapy and Others, investors and consultants, and government or industry bodies who need market size, segmentation, competitive and regional data for the Lutetium-177 (Lu-177) market.
What license options are available for this report?
The report is available as a Single User License (US$ 3,500, one named user), a Site License (US$ 5,250, up to 10 users) and a Global / Corporate License (US$ 7,000, unlimited users), all delivered in PDF format.

Research Methodology

All MarketResearchReports.com strategic research reports follow a rigorous, multi-stage methodology combining AI-assisted data synthesis with expert analyst validation.

01
Secondary Research & Data Aggregation

Systematic collection from 500+ verified sources including SEC filings, industry databases (Bloomberg, Statista, OECD), regulatory filings, trade publications, patent databases, and company annual reports. AI-assisted extraction identifies relevant data points across 10,000+ documents per report.

02
Market Sizing — Bottom-Up & Top-Down

Dual-validation approach: bottom-up sizing aggregates segment-level production, consumption, and trade data; top-down sizing cross-validates against macroeconomic indicators and total addressable market estimates. Discrepancies >5% trigger analyst review.

03
Competitive Intelligence

Company profiles built from public financial disclosures, product launches, M&A activity, job postings (as capability proxies), and supply chain mapping. Market share estimates triangulated across revenue, capacity, and shipment data.

04
Demand Forecasting

CAGR projections use time-series regression on 5-10 years of historical data, adjusted for identified demand drivers (technology adoption curves, regulatory catalysts, demographic shifts) and demand inhibitors (cost barriers, substitution risk). Scenario modeling covers base, optimistic, and conservative cases.

05
Analyst Validation & Quality Assurance

All quantitative outputs reviewed by a domain-specialist analyst before publication. Data triangulation requires minimum 3 independent sources for every key figure. Reports undergo a structured peer review against our 47-point quality checklist covering methodology, data citations, logical consistency, and formatting standards.

06
Continuous Updates

On-demand reports are generated at time of purchase, incorporating the most recent available data. Static reports are republished when underlying market conditions shift by >10% from baseline assumptions. Purchasers receive update notifications for 12 months.

All data sources are cited within the report. View our full research methodology →
Select a license
from US$ 3.500,00
Report License Type
Optional add-ons
On demand · delivered within 24-48 hours
Secure checkout · SSL encrypted
License terms included
Post-purchase analyst support
Custom research

Need a customized version?

Get country-, segment- or company-specific intelligence tailored to your exact requirements.

Request custom research →
Talk to a research advisor USA: +1-302-703-9904 India: +91-8762746600
Trusted by

Leading Brands in This Industry

Logos are trademarks of their respective owners and indicate a verified past business relationship, not a current partnership or endorsement.